Ask AI
ProCE Banner Activity

Therapy Trends & Tipping Points in MS: A Case-Based Look at High-Risk Disease and Emerging Treatments

Podcast Episodes

Explore what’s next in multiple sclerosis (MS) care, spotlighting CNS-penetrant oral BTK inhibitors and a broader pipeline targeting neuroinflammation, immune reset, and future CNS repair. Also featured is a real patient case to highlight practical decisions around therapy selection and when to switch treatment, guided by Patricia K. Coyle, MD, FAAN, FANA.

Released: March 13, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

This activity is intended for healthcare professionals in neurology who provide care for patients with MS, including physicians, nurse practitioners, physician associates, and pharmacists. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the immunopathogenic mechanisms and biologic basis of MS in the context of available treatment options

  • Evaluate clinical trial data on approved and emerging DMTs for relapsing MS

  • Apply efficacy, safety, and disease activity metrics to tailor treatment selection and monitoring plans for relapsing MS

  • Incorporate evidence-based communication techniques and multidisciplinary care approaches to support shared decision-making, improve adherence, and optimize long-term outcomes in MS management

Disclosure

Primary Author

Patricia K. Coyle, MD, FAAN, FANA: consultant/advisor/speaker: Accordant, Amgen, GSK, Horizon Therapeutics, Novartis, Sanofi Genzyme; researcher: CorEvitas, Genentech/Roche, Sanofi Genzyme.